STOCK TITAN

Cellebrite DI Ltd. - CLBT STOCK NEWS

Welcome to our dedicated page for Cellebrite DI Ltd. news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite DI Ltd. stock.

Cellebrite DI Ltd. (Nasdaq: CLBT) is an Israeli digital intelligence company renowned for delivering comprehensive tools and solutions to federal, state, and local law enforcement, as well as enterprise companies and service providers. The company’s offerings assist in the collection, review, analysis, and management of digital data.

Core Business: Cellebrite's suite of products includes the UFED series for data extraction from mobile devices, Physical Analyzer for deep digital data analysis, UFED Cloud for cloud data retrieval, Frontliner, Responder, Premium, and Seeker, each designed to serve different aspects of digital investigations.

Recent Achievements and Projects: Recently, Cellebrite has partnered with Coalfire to enable U.S. federal customers to access Cellebrite's SaaS technology. This collaboration is part of Cellebrite's ongoing efforts to achieve FedRAMP authorization, ensuring the highest standards of security and data compliance for its SaaS solutions.

Financial Condition: For the first quarter of 2024, the company reported strong financial performance with expanded business globally and improved profitability. Cellebrite has reaffirmed its optimistic outlook for the remainder of the year, expecting to drive substantial revenue and adjusted EBITDA growth.

Partnerships: Collaborating with cybersecurity leader Coalfire, Cellebrite aims to strengthen its FedRAMP authorization process, reflecting a commitment to robust security standards.

Products and Solutions: Cellebrite’s SaaS-based solutions, like Guardian and Endpoint Inspector SaaS, offer scalable, secure data management and evidence sharing, enhancing operational efficiency and collaboration between investigators. These solutions ensure consent-based data collection, adhering to ethical and legal standards.

Significance: Cellebrite’s mission is to protect and save lives, accelerate justice, and preserve privacy. Their digital investigative solutions empower organizations to master the complexities of legally sanctioned investigations, transforming data collection and analysis processes. Trusted globally, their platform is instrumental in advancing digital investigations for both public and private sectors.

Rhea-AI Summary

Cellebrite (NASDAQ: CLBT), a global leader in Digital Investigative solutions, has announced it will release its fourth-quarter and fiscal year 2024 financial results before market open on Thursday, February 13, 2025.

The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the Q4 2024 results and provide outlook for 2025. Historical financial tables and supplemental data will be made available on the company's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
conferences earnings
-
Rhea-AI Summary

Cellebrite (NASDAQ: CLBT), a global leader in digital investigative solutions, has announced its participation in the upcoming Needham & Company 27th Annual Growth Conference.

The event will take place on January 14, 2025, with Cellebrite's presentation scheduled for 8:45 a.m. ET. The presentation format will be a Fireside Chat and can be accessed via the event URL: https://investors.cellebrite.com/events/event-details/needham-co-27th-annual-growth-conference.

Key executives representing Cellebrite at the conference will be Dana Gerner, Chief Financial Officer, and Andrew Kramer, Vice President, Investor Relations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
none
-
Rhea-AI Summary

Cellebrite (NASDAQ: CLBT), a global leader in Digital Investigative solutions, announced key updates to its Board of Directors to bolster the company's growth in 2025 and beyond. As of January 1, 2025, Thomas E. Hogan has been confirmed as interim CEO, while maintaining his role on the Board, with plans to revert to chairman once a new CEO is appointed. Adam H. Clammer, Managing Partner of True Wind Capital Management, has taken on the role of board chairman, adhering to best practices in board governance by separating the CEO and board chair duties.

Additionally, Michael D. Capellas, with extensive leadership experience across top technology companies, joins Cellebrite's Board as a Class II director and the new lead independent director, replacing Adam Clammer. Capellas's notable roles include CEO positions at VCE, First Data , MCI, Compaq Computer , and President at Hewlett-Packard.

Capellas expressed enthusiasm for joining Cellebrite, highlighting his commitment to justice, safety, and security, and his alignment with the company's mission to combat child exploitation and trafficking.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.63%
Tags
management
Rhea-AI Summary

D-Fend Solutions has secured $31M in a new investment round led by Israel Growth Partners (IGP), with participation from Vertex Ventures and Vertex Growth. The company, specializing in RF cyber-based counter-drone technology, reported over 60% year-over-year revenue growth and expansion across nearly 30 countries, including Five Eyes alliance, G7, and NATO member states.

The funding will support technological advancement, market expansion, and addressing evolving drone threats. D-Fend's flagship product, EnforceAir, uses RF cyber-takeover techniques to neutralize rogue drones safely without operational disruption. The technology has been recognized by Booz Allen Hamilton and is deployed to protect military zones, airports, critical infrastructure, prisons, and public events.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.99%
Tags
none
-
Rhea-AI Summary

Cellebrite (NASDAQ: CLBT), a global leader in Digital Investigative solutions, announced its participation in the upcoming UBS Global Technology and AI Conference. The company will participate in a fireside chat on December 3, 2024, at 4:55 p.m. ET. Key executives attending include Thomas Hogan (executive chairman), Dana Gerner (CFO), and Andrew Kramer (VP of investor relations).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.37%
Tags
AI
-
Rhea-AI Summary

Cellebrite (Nasdaq: CLBT) and Relativity announced the general availability of Cellebrite's mobile collection solutions integration into RelativityOne platform. The integration enables faster and more efficient mobile data management in legal processes. Following a successful Advanced Access program in July 2024, users reported significant efficiency gains, reducing mobile device data collection time to just over an hour compared to previous days or weeks. The integration allows remote mobile device collections to be fully orchestrated within RelativityOne, including custodian notification and automatic data transfer. According to Cellebrite's 2024 Industry Trends survey, 97% of eDiscovery cases now involve at least one mobile device.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.28%
Tags
none
Rhea-AI Summary

Cellebrite reported strong Q3 2024 financial results, achieving a significant milestone with quarterly revenue exceeding $100 million for the first time. Revenue reached $106.9 million, up 27% year-over-year, driven by 27% growth in subscription revenue to $93.4 million. The company's Annual Recurring Revenue (ARR) grew 26% to $370.8 million, with a net retention rate of 124%.

Key highlights include adjusted EBITDA of $31.3 million with a 29.3% margin. The company announced Pathfinder in the Cloud with AWS and received a patent for Remote Mobile Collection. Based on strong performance, Cellebrite increased its 2024 outlook for revenue to $397-401 million and adjusted EBITDA to $94-100 million, while raising the low end of its ARR target range to $390-400 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
-
Rhea-AI Summary

Cellebrite (NASDAQ: CLBT) announced that CEO Yossi Carmil will step down from his position and Board of Directors by December 31, 2024. Executive Chairman Thomas E. Hogan will serve as interim CEO while the company conducts a formal search for a new chief executive. Under Carmil's 19-year leadership, Cellebrite grew from 18 to over 1,100 employees, expanded to dozen offices worldwide, and serves approximately 7,000 customers in more than 100 countries. Notable achievements include taking the company public in 2021, transitioning to a subscription business model, and launching the AI-driven Case-to-Closure platform. The company's market valuation has doubled to approximately $4 billion since going public.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
none
-
Rhea-AI Summary

Cellebrite (NASDAQ: CLBT) reported strong Q3 2024 results, achieving a milestone of $106.9 million in quarterly revenue, up 27% year-over-year. Subscription revenue grew 27% to $93.4 million, while Annual Recurring Revenue (ARR) reached $370.8 million, up 26% year-over-year. The company reported an Adjusted EBITDA of $31.3 million with a 29.3% margin. Despite posting a GAAP net loss of $207.1 million, non-GAAP net income was $31.8 million. Based on strong performance, Cellebrite increased its 2024 outlook for revenue and adjusted EBITDA, raising the low end of the ARR target range to $390-400 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
Rhea-AI Summary

Cellebrite (NASDAQ: CLBT) announced Tim Tebow as the keynote speaker for their inaugural Case-to-Closure (C2C) User Summit scheduled for March 31-April 3, 2025, in Washington, D.C. The summit will gather digital investigation leaders to discuss industry trends and best practices. Tebow will address his foundation's global fight against human trafficking, aligning with Cellebrite's Operation Find Them All initiative. The event will feature over three dozen speakers covering various digital investigative topics, including notable case studies and technological developments. Attendees will have opportunities for networking, professional training, and knowledge expansion across different levels of the investigative process.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.32%
Tags
none

FAQ

What is the current stock price of Cellebrite DI Ltd. (CLBT)?

The current stock price of Cellebrite DI Ltd. (CLBT) is $22.78 as of January 17, 2025.

What is the market cap of Cellebrite DI Ltd. (CLBT)?

The market cap of Cellebrite DI Ltd. (CLBT) is approximately 4.9B.

What does Cellebrite DI Ltd. specialize in?

Cellebrite DI Ltd. specializes in providing digital intelligence tools for data collection, review, analysis, and management to law enforcement agencies and enterprise companies.

What are some of the key products offered by Cellebrite?

Key products include Cellebrite UFED, Physical Analyzer, UFED Cloud, Frontliner, Responder, Premium, and Seeker.

What recent collaboration has Cellebrite engaged in?

Cellebrite recently collaborated with Coalfire to enhance security and data compliance for U.S. federal customers through SaaS technology.

What are Cellebrite's financial expectations for 2024?

Cellebrite expects to drive solid annual recurring revenue and adjusted EBITDA growth, particularly in the second half of 2024.

How does Cellebrite ensure the security of its solutions?

Cellebrite partners with cybersecurity leaders and adheres to robust security and data compliance standards, as demonstrated by their FedRAMP authorization efforts.

What is Cellebrite's mission?

Cellebrite’s mission is to protect and save lives, accelerate justice, and preserve privacy through its digital investigative solutions.

Who are the typical users of Cellebrite’s products?

Typical users include federal, state, and local law enforcement agencies, enterprise companies, and service providers involved in digital investigations.

What makes Cellebrite’s SaaS solutions unique?

Cellebrite’s SaaS solutions, such as Guardian and Endpoint Inspector SaaS, provide scalable, secure, and consent-based data collection and management for efficient digital investigations.

Where can investors find detailed financial information about Cellebrite?

Investors can find detailed financial information on Cellebrite’s investor relations website at https://investors.cellebrite.com.

How does Cellebrite contribute to digital investigations?

Cellebrite’s platform and solutions streamline the process of collecting, analyzing, and managing digital data, making it easier for investigators to handle complex digital cases.
Cellebrite DI Ltd.

Nasdaq:CLBT

CLBT Rankings

CLBT Stock Data

4.93B
101.02M
46.79%
52.94%
0.48%
Software - Infrastructure
Technology
Link
United States of America
Petah Tikva